does medicare cover glp-1 drugs CMS Issues Coverage Guidance on Anti-Obesity Poll: 1 in 8 Adults

not using GLP-1 receptor agonists had significantly lower relative risks for mortality and respiratory failure, according to a presentation at the CHEST Annual Meeting.In a retrospective study, Saud Alawad, MBBS, third-year internal medicine resident at West Virginia University, and colleagues analyzed adults with a group 1 PAH

As fatty liver disease continues to drive downstream costs, this signal is getting serious attention

You'll find hundreds of products containing Berberine, Akkermansia, Probiotics

Support your healthy lifestyle with our innovative botanical patches, designed to complement your weight management

2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

Explore their functions and potential use in treating diabetes and obesity.